02755nam 2200601Ia 450 991045818850332120200520144314.01-282-78742-X97866127874230-309-15130-9(CKB)2560000000015980(EBL)3378636(SSID)ssj0000417279(PQKBManifestationID)11267613(PQKBTitleCode)TC0000417279(PQKBWorkID)10361258(PQKB)10448333(MiAaPQ)EBC3378636(Au-PeEL)EBL3378636(CaPaEBR)ebr10405099(CaONFJC)MIL278742(OCoLC)923281847(EXLCZ)99256000000001598020100511d2010 uy 0engurcn|||||||||txtccrEvaluation of biomarkers and surrogate endpoints in chronic disease[electronic resource] /Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease, Board on Health Care Services, Board on Health Sciences Policy, Food and Nutrition Board, Institute of Medicine ; Christine M. Micheel and John R. Ball, editorsWashington, DC National Academies Pressc20101 online resource (335 p.)Description based upon print version of record.0-309-15129-5 Includes bibliographical references.""Front Matter""; ""Reviewers""; ""Preface""; ""Acknowledgments""; ""Contents""; ""Boxes, Figures, and Tables""; ""Summary""; ""1 Introduction""; ""2 Review: Evaluating and Regulating Biomarker Use""; ""3 The Biomarker Evaluation Process""; ""4 Case Studies""; ""5 Strengthening Evidence-Based Regulation""; ""Acronyms""; ""Glossary""; ""Appendix A: Table of Papers About Biomarker Qualification""; ""Appendix B: Recommendations from Related IOM Reports""; ""Appendix C: Committee Member and Consultant Biographies""; ""Appendix D: Staff Biographies""; ""Appendix E: Workshop Agenda""""Appendix F: Speaker Biographies""Biochemical markersEvaluationChronic diseasesElectronic books.Biochemical markersEvaluation.Chronic diseases.610.28Micheel Christine870814Ball John1944-955362Institute of Medicine (U.S.).Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease.MiAaPQMiAaPQMiAaPQBOOK9910458188503321Evaluation of biomarkers and surrogate endpoints in chronic disease2161548UNINA